Clinical Trial Update: Study to Evaluate the Pharmacokinetics of Velpatasvir in Participants With Normal Renal Function and Severe Renal Impairment [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study evaluating velpatasvir in participants with normal renal function and severe renal impairment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Velpatasvir (velpatasvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C Virus | Phase 1 | Status: COMPLETED | Results posted: 2020-11-16